Vincerx Pharma, Inc. (VINC)
OTCMKTS · Delayed Price · Currency is USD
0.0370
-0.0028 (-6.98%)
At close: Aug 12, 2025
Everbridge Market Cap
Vincerx Pharma has a market cap or net worth of $193.77 thousand as of August 13, 2025. Its market cap has decreased by -99.00% in one year.
Market Cap
193.77K
Enterprise Value
-4.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since May 27, 2020, Vincerx Pharma's market cap has decreased from 22.32M to 193.77K, a decrease of -99.13%. That is a compound annual growth rate of -59.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 208.32K | -97.64% |
| Dec 31, 2024 | 8.84M | -64.95% |
| Dec 29, 2023 | 25.23M | 16.73% |
| Dec 30, 2022 | 21.61M | -89.91% |
| Dec 31, 2021 | 214.20M | -26.75% |
| Dec 31, 2020 | 292.41M | 1,210.19% |
| May 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.19M |
| Glass House Brands | 543.74M |
| American Oncology Network | 393.37M |
| Northwest Biotherapeutics | 332.06M |
| CytoDyn | 300.75M |